Efficacy of Switching to Adalimumab for Maintenance of Remission Following Induction Therapy with Tacrolimus in Patients with Ulcerative Colitis

Background: Tacrolimus (TAC) effectively induces remission in refractory ulcerative colitis (UC). However, TAC therapy usually lasts for 3 months. Although azathioprine (AZA) is often used in maintenance therapy, the relapse rate remains high. Herein, we evaluated the efficacy of adalimumab (ADA) fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Numa, Keijiro, Kakimoto, Kazuki, Tanaka, Yasuyoshi, Mizuta, Noboru, Kinoshita, Naohiko, Nakazawa, Kei, Koshiba, Ryoji, Hirata, Yuki, Ota, Kazuhiro, Miyazaki, Takako, Nakamura, Shiro, Higuchi, Kazuhide, Nishikawa, Hiroki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607785/
https://www.ncbi.nlm.nih.gov/pubmed/37892837
http://dx.doi.org/10.3390/jcm12206699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607785/
https://www.ncbi.nlm.nih.gov/pubmed/37892837
http://dx.doi.org/10.3390/jcm12206699

Ejemplares similares